Man Investments (UK)’s PDL BioPharma, Inc. PDLI Stock Holding History

Man Investments (UK)’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$323K	Buy	+33,334	New	+$297K	0.03%	622

Other funds holding PDLI

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Man Investments (UK)'s PDLI Position: Q2 2014 in Review

Man Investments (UK) opened a new position in PDL BioPharma, Inc. (PDLI) in Q2 2014: 33,334 shares worth $323K. The stake represents 0.03% of the portfolio and ranks #622 among its holdings.

222 funds tracked by Wall St. Rank hold PDLI as of Q2 2014.

Man Investments (UK) held 33,334 shares of PDL BioPharma, Inc. worth $323K as of Q2 2014.
PDL BioPharma, Inc. was a new Man Investments (UK) position in Q2 2014.
PDL BioPharma, Inc. made up 0.03% of Man Investments (UK)'s portfolio in Q2 2014, its #622 holding.
222 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2014.

Based on Man Investments (UK)'s 13F filing for Q2 2014, filed 14 Aug 2014.